Over the past 12 months, Kiniksa Pharmaceuticals International insiders sold $107.54 million of stock on the open market (1.57Mn shares) and made no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Bros. Advisors Lp Baker | Director | 0 | 5,470,583 | 5,470,583 | 73.4% | 02 Jun, 2026 |
| 2 | Sanj K Patel | Chairman Ceo | 63,012 | 1,406,197 | 1,469,209 | 19.7% | 03 Nov, 2026 |
| 3 | Eben Tessari | Chief Strategy Officer | 149,154 | 0 | 149,154 | 2.0% | 08 Apr, 2026 |
| 4 | John F. Paolini | Chief Medical Officer | 117,725 | 0 | 117,725 | 1.6% | 03 Nov, 2026 |
| 5 | Mark Ragosa | Chief Financial Officer | 40,107 | 0 | 40,107 | 0.5% | 03 Nov, 2026 |
| 6 | Richard S Levy | Director | 35,256 | 0 | 35,256 | 0.5% | 04 Aug, 2026 |
| 7 | Michael R Megna | Chief Accounting Officer | 34,025 | 0 | 34,025 | 0.5% | 03 Nov, 2026 |
| 8 | Ross Moat | Chief Operating Officer | 26,570 | 0 | 26,570 | 0.4% | 03 Nov, 2026 |
| 9 | Kimberly J Popovits | Director | 24,718 | 0 | 24,718 | 0.3% | 02 Jun, 2026 |
| 10 | Thomas Malley | Director | 24,718 | 0 | 24,718 | 0.3% | 02 Jun, 2026 |
| 11 | Tracey L Mccain | Director | 24,718 | 0 | 24,718 | 0.3% | 02 Jun, 2026 |
| 12 | Barry D Quart | Director | 22,118 | 0 | 22,118 | 0.3% | 21 Aug, 2026 |
| 13 | G Bradley Cole | Director | 16,545 | 0 | 16,545 | 0.2% | 31 Jul, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 30 Oct, 2026 | Ross Moat | Chief Operating Officer | Acquired M | 16,111 | $10.76 | $173.35K | 32,418 | Direct |
| 30 Oct, 2026 | Michael R Megna | Chief Accounting Officer | Acquired M | 4,689 | $10.76 | $50.45K | 33,751 | Direct |
| 30 Oct, 2026 | Sanj K Patel | Chairman Ceo | Acquired M | 47,530 | $8.83 | $419.69K | 999,324 | Indirect |
| 30 Oct, 2026 | John F. Paolini | Chief Medical Officer | Acquired M | 38,545 | $30.93 | $1.19Mn | 108,467 | Direct |
| 02 Nov, 2026 | Mark Ragosa | Chief Financial Officer | Acquired M | 9,636 | $10.76 | $103.68K | 30,490 | Direct |
| 30 Oct, 2026 | Ross Moat | Chief Operating Officer | Acquired M | 21,059 | $11.10 | $233.75K | 53,477 | Direct |
| 30 Oct, 2026 | John F. Paolini | Chief Medical Officer | Acquired M | 39,042 | $17.92 | $699.63K | 147,509 | Direct |
| 02 Nov, 2026 | Mark Ragosa | Chief Financial Officer | Acquired M | 5,388 | $11.10 | $59.81K | 35,878 | Direct |
| 30 Oct, 2026 | Sanj K Patel | Chairman Ceo | Disposed S | 41,169 | $92.01 | $3.79Mn | 958,155 | Indirect |
| 30 Oct, 2026 | Michael R Megna | Chief Accounting Officer | Acquired M | 3,932 | $11.10 | $43.65K | 37,683 | Direct |
| 30 Oct, 2026 | Sanj K Patel | Chairman Ceo | Disposed S | 18,685 | $92.77 | $1.73Mn | 939,470 | Indirect |
| 02 Nov, 2026 | Mark Ragosa | Chief Financial Officer | Acquired M | 12,123 | $11.97 | $145.11K | 48,001 | Direct |
| 30 Oct, 2026 | Michael R Megna | Chief Accounting Officer | Acquired M | 7,209 | $11.97 | $86.29K | 44,892 | Direct |
| 30 Oct, 2026 | Ross Moat | Chief Operating Officer | Acquired M | 3,760 | $11.97 | $45.01K | 57,237 | Direct |
| 30 Oct, 2026 | John F. Paolini | Chief Medical Officer | Disposed S | 41,789 | $92.02 | $3.85Mn | 105,720 | Direct |
| 30 Oct, 2026 | Ross Moat | Chief Operating Officer | Acquired M | 1,658 | $12.97 | $21.50K | 58,895 | Direct |
| 30 Oct, 2026 | Sanj K Patel | Chairman Ceo | Disposed S | 15,903 | $93.62 | $1.49Mn | 923,567 | Indirect |
| 30 Oct, 2026 | John F. Paolini | Chief Medical Officer | Disposed S | 16,056 | $92.85 | $1.49Mn | 89,664 | Direct |
| 30 Oct, 2026 | Michael R Megna | Chief Accounting Officer | Acquired M | 4,065 | $17.76 | $72.19K | 48,957 | Direct |
| 02 Nov, 2026 | Mark Ragosa | Chief Financial Officer | Acquired M | 9,636 | $17.76 | $171.14K | 57,637 | Direct |